Pharmaceutical

Sobi and Enable Injections partner for Aspaveli distribution

Sobi and Enable Injections have entered an agreement for the development and distribution of Aspaveli in combination with enFuse.

Sep 14, 2024 - 04:00
Sobi and Enable Injections partner for Aspaveli distribution
Sobi and Enable Injections have entered an agreement for the development and distribution of Aspaveli in combination with enFuse.
Read the original article

Tags:

Previous Article

Cidara axes 30% of staff to focus on flu prevention drug

Next Article

FDA approves Roche’s Tecentriq Hybreza for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Congressmen: This Covid hearing ‘could have been an email’

Congressmen: This Covid hearing ‘could have been an email’

Feb 1, 2024

CatalYm secures $150m to advance GDF-15-targeting immune modulator   

CatalYm secures $150m to advance GDF-15-targeting immun...

Jul 18, 2024

STAT+: Hospitals struggle to validate AI-generated clinical summaries. ‘It’s a bit chaotic’

STAT+: Hospitals struggle to validate AI-generated clin...

Mar 13, 2024